Genomma Lab stock pre-market: pharmaceutical and personal care group
Published on 10/20/2026 at 08:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and early indication
- In an October 15, 2026 release, Genomma Lab described operations spanning product development, marketing, retail distribution and supply chain activities.
- The company said it operates in 18 countries.
- Genomma Lab stock trades pre-market at EUR 0.70 at 8:23 a.m. CEST at Lang & Schwarz on October 20, 2026.
Genomma Lab develops, sells and markets branded pharmaceutical and personal care products in Latin America, using product development, consumer-oriented marketing, retail distribution and a flexible supply chain across 18 countries, according to an October 15, 2026 PR Newswire release.
Genomma Lab stock trades pre-market at EUR 0.70 at 8:23 a.m. CEST at Lang & Schwarz on October 20, 2026.
Ahead of the Xetra open
The early indication is being monitored before the German session begins. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Genomma Lab stock.
Business model
The company earns revenue by developing, marketing and distributing branded health and personal care products through retail channels in Latin America, while operating a flexible supply chain, the October 15, 2026 release said. Market context: Latest market reports.
